Prevent complications

TRELAS - TRoponin ELevation in Acute Stroke

In 5-34% of patients with acute ischemic stroke increased troponins are found. Regarding the optimal care for these patients, there is little evidence.
More information/project description

Research Group Endres
Research Group Nolte

Project Description

The primary objective of the prospective observational trial TRELAS (TRoponin ELevation in Acute ischemic Stroke) is to elucidate the underlying pathomechanism of cTnT elevation in acute ischemic stroke. Consecutive patients with acute ischemic stroke admitted to the Department of Neurology Campus Benjamin Franklin of the university hospital Charité will be screened for cTnT elevations suggestive of myocardial infarction (>0,05 µg/l). Patients with increased troponin will undergo diagnostic coronary angiography within 72 hours. Diagnostic findings of coronary angiographies taken out in age- and gender-matched patients presenting with NSTE-ACS (Non-ST-Elevation Acute Coronary Syndrome) to the Division of Cardiology will serve as a control. The primary endpoint of the study will be the occurrence of culprit lesions indicating focal cardiac damage on the basis of an acute CAD.

Contact
Jan Scheitz

PubMed

Back to overview
Logo Charité Berlin Logo Center for Stroke Research Berlin
© 2018 CSB | TYPO3 Website made by Kombinat Berlin